Approval Granted for Construction of State of the Art Synchotron Light Source II

To advance its science mission that focuses on critical national challenges, the U.S. Department of Energy (DOE) has approved the construction start of the state-of-the-art National Synchrotron Light Source II (NSLS-II) at Brookhaven National Laboratory.

DOE has granted "Critical Decision 3" (CD-3) status to the NSLS-II, approving the start of construction in fiscal year (FY) 2009 and scheduling completion in FY 2015. DOE has approved a total project cost for NSLS-II of $912 million.

“NSLS-II is the largest capital project under construction at any of the 10 national laboratories throughout the country that are owned by the Department of Energy’s Office of Science,” said DOE’s Brookhaven Site Office Manager Mike Holland. “This represents a major investment by the Department of Energy in Brookhaven National Laboratory and ensures the scientific vitality of Brookhaven, one of the nation’s premier research laboratories, for at least 25 years into the future.”

NSLS-II will be a medium-energy storage ring with a unique design that will deliver world-leading brightness and flux and exceptional beam stability. The machine will be the newest member of a suite of advanced light sources and neutron facilities operated by DOE's Office of Science that are used by more than 9,000 researchers annually from all disciplines. The NSLS-II will advance exploration of the scientific challenges faced in developing new materials with advanced properties, enabling their study, particularly at the nanoscale, at a level of detail and precision never before possible.

"NSLS-II will provide the world's finest capabilities for x-ray imaging, with unprecedented spatial and energy resolution and the ability to detect single atoms," said Steven Dierker, Associate Laboratory Director for Light Sources. “It will provide advanced tools for discovery-class science in condensed matter and materials physics, chemistry, and biology – science that ultimately will enhance national and energy security and help drive abundant, safe, and clean energy technologies.”

The scientific advances resulting from research at the new facility will support technological and economic development in multiple sectors of the economy, from next-generation energy technologies to new drugs for fighting disease, Dierker said.

CD-3 is the fourth of five critical decisions that the project will need to achieve in order to progress through the successively more detailed stages of conceptual design, preliminary design, final design, construction, and then operations. A CD-3 approves the start of construction and signifies that a final design review has been performed, that all environmental and safety criteria have been met, all security concerns addressed and the project is ready to begin construction. CD-3 authorizes the project to commit all the resources necessary to execute the project, within the funds provided. CD-2, approving the facility’s performance baseline, was announced in December 2007, and CD-1, siting the facility at DOE's Brookhaven and approving its cost range, was announced in July 2007.

NSLS-II will replace the existing NSLS, which began operations in 1982. NSLS provides essential scientific tools for 2,300 scientists each year from more than 400 academic, industrial and government institutions.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.